ZA921541B - Peptide analogues - Google Patents

Peptide analogues

Info

Publication number
ZA921541B
ZA921541B ZA921541A ZA921541A ZA921541B ZA 921541 B ZA921541 B ZA 921541B ZA 921541 A ZA921541 A ZA 921541A ZA 921541 A ZA921541 A ZA 921541A ZA 921541 B ZA921541 B ZA 921541B
Authority
ZA
South Africa
Prior art keywords
peptide analogues
analogues
peptide
Prior art date
Application number
ZA921541A
Inventor
Horst Juraszyk
Juraszyk Horst
Johannes Sombroek
Sombroek Johannes
Claus J Schmitges
J Schmitges Claus
Peter Raddatz
Raddatz Peter
Joachim Gante
Gante Joachim
Klaus-Otto Minck
Minck Klaus-Otto
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA921541B publication Critical patent/ZA921541B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA921541A 1991-03-01 1992-02-28 Peptide analogues ZA921541B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4106488A DE4106488A1 (en) 1991-03-01 1991-03-01 PEPTIDE ANALOGS

Publications (1)

Publication Number Publication Date
ZA921541B true ZA921541B (en) 1992-11-25

Family

ID=6426198

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA921541A ZA921541B (en) 1991-03-01 1992-02-28 Peptide analogues

Country Status (12)

Country Link
EP (1) EP0501280A2 (en)
JP (1) JPH05117297A (en)
KR (1) KR920018073A (en)
AU (1) AU1130292A (en)
CA (1) CA2062065A1 (en)
CS (1) CS56992A3 (en)
DE (1) DE4106488A1 (en)
HU (1) HU9200678D0 (en)
IE (1) IE920655A1 (en)
MX (1) MX9200862A (en)
PT (1) PT100179A (en)
ZA (1) ZA921541B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008403A1 (en) * 1990-03-16 1991-09-19 Merck Patent Gmbh GLYKOLSAEUREDERIVATE
EP4308170A1 (en) 2021-03-18 2024-01-24 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds

Also Published As

Publication number Publication date
CS56992A3 (en) 1992-11-18
HU9200678D0 (en) 1992-05-28
MX9200862A (en) 1992-09-01
PT100179A (en) 1993-05-31
DE4106488A1 (en) 1992-09-03
KR920018073A (en) 1992-10-21
JPH05117297A (en) 1993-05-14
CA2062065A1 (en) 1992-09-02
EP0501280A2 (en) 1992-09-02
AU1130292A (en) 1992-09-03
IE920655A1 (en) 1992-09-09

Similar Documents

Publication Publication Date Title
ZA928511B (en) Peptides
GB2269176B (en) Peptides
HU9401474D0 (en) New peptide derivatives
EP0515681A4 (en) Peptide compound
HU9400589D0 (en) New isosteric peptides
HU9302847D0 (en) Fluor-containing d3-vitamin analogues
GB9325519D0 (en) Peptides
ZA915978B (en) Peptides
GB9214830D0 (en) Peptide compositions
AP9200452A0 (en) Hemoregulatory peptides
ZA921541B (en) Peptide analogues
HU9202048D0 (en) Insuline analogues
GB9211677D0 (en) Peptide compounds
LV10287B (en) Peptide compounds
GB9105871D0 (en) Synthetic peptides
GB9102655D0 (en) New peptides
GB9102818D0 (en) New peptides
GB9226074D0 (en) Peptide
GB9107752D0 (en) Antiviral peptides
GB9114507D0 (en) Antiviral peptides
GB9008361D0 (en) Modified peptide
AU397P (en) 9582 Glycine max
AU402P (en) 9791 Glycine max
AU398P (en) 9641 Glycine max
GB9005854D0 (en) Peptide compounds